Title,Code,"Demographic Group",Population,Period,Estimate,Unit,"Lower CI","Upper CI",SE,Locality,"Disparity Group Rank","Disparity Rate Ratio","Disparity Lower CI","Disparity Upper CI","Disparity SE" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Total *",Total,2018,9.9,"per 100,000",,,0.057,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sex *",Male,2018,14.2,"per 100,000",,,0.097,"United States",2,2.574,1,2.628,0.013 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sex *",Female,2018,5.5,"per 100,000",,,0.060,"United States",1,1,1,1.026,0.015 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","American Indian or Alaska Native only",2018,4.4,"per 100,000",,,0.330,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Asian only",2018,0.9,"per 100,000",,,0.066,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Native Hawaiian or Other Pacific Islander only",2018,DSU,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Black or African American only",2018,10.8,"per 100,000",,,0.158,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","White only",2018,10.9,"per 100,000",,,0.069,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","2 or more races",2018,3.6,"per 100,000",,,0.232,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Hispanic or Latino",2018,4.7,"per 100,000",,,0.091,"United States",3,5.365,1,6.09, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino",2018,11.1,"per 100,000",,,0.067,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: American Indian or Alaska Native only",2018,7.0,"per 100,000",,,0.561,"United States",4,7.986,1,9.561, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Asian only",2018,0.9,"per 100,000",,,0.066,"United States",1,1,1,1.19, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Native Hawaiian or Other Pacific Islander only",2018,DSU,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Black or African American only",2018,11.2,"per 100,000",,,0.166,"United States",5,12.731,1,14.429, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: White only",2018,12.7,"per 100,000",,,0.086,"United States",6,14.527,1,16.434,0.085 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: 2 or more races",2018,4.0,"per 100,000",,,0.278,"United States",2,4.559,1,5.392, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","less than 18 years",2018,0.1,"per 100,000",,,0.014,"United States",1,1,1,1.26, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 0-4 years",2018,DSU,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 5-11 years",2018,DSU,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 12-17 years",2018,0.3,"per 100,000",,,0.036,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years",2018,17.2,"per 100,000",,,0.121,"United States",4,125.044,1,147.34,0.1 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years: 18-24 years",2018,8.4,"per 100,000",,,0.166,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years: 25-44 years",2018,20.3,"per 100,000",,,0.153,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years",2018,12.1,"per 100,000",,,0.120,"United States",3,87.913,1,103.63, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years: 45-54 years",2018,14.7,"per 100,000",,,0.188,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years: 55-64 years",2018,9.5,"per 100,000",,,0.150,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over",2018,1.7,"per 100,000",,,0.056,"United States",2,12.073,1,14.351, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 65-74 years",2018,2.6,"per 100,000",,,0.092,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 75-84 years",2018,0.4,"per 100,000",,,0.051,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 85 years and over",2018,DSU,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","Less than High school",2018,30.2,"per 100,000",,,0.429,"United States",2,4.244,1,4.374, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","High school (including GED or equivalent)",2018,35.9,"per 100,000",,,0.307,"United States",3,5.044,1,5.166,0.02 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","Some college or more",2018,7.1,"per 100,000",,,0.083,"United States",1,1,1,1.028, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Family income *","Family income",2018,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Health insurance status *","Health insurance status",2018,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Geographic location *",Metropolitan,2018,10.3,"per 100,000",,,0.062,"United States",2,1.453,1,1.501,0.02 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Geographic location *",Non-metropolitan,2018,7.1,"per 100,000",,,0.136,"United States",1,1,1,1.045,0.027 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *",Married,2018,4.3,"per 100,000",,,0.063,"United States",1,1,1,1.034, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *","Divorced, separated, widowed",2018,24.4,"per 100,000",,,0.366,"United States",2,5.632,1,5.828, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *","Never married",2018,30.2,"per 100,000",,,0.272,"United States",3,6.986,1,7.184,0.022 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Country of birth *",US,2018,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Country of birth *","Outside US",2018,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Veteran status *","Veteran status",2018,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Disability status *","Disability status",2018,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sexual orientation *","Sexual orientation",2018,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Gender identity *","Gender identity",2018,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Total *",Total,2019,11.4,"per 100,000",,,0.061,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sex *",Male,2019,16.6,"per 100,000",,,0.104,"United States",2,2.637,1,2.69,0.012 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sex *",Female,2019,6.3,"per 100,000",,,0.064,"United States",1,1,1,1.024,0.014 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","American Indian or Alaska Native only",2019,6.7,"per 100,000",,,0.404,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Asian only",2019,1.1,"per 100,000",,,0.073,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Native Hawaiian or Other Pacific Islander only",2019,2.6,"per 100,000",,,0.546,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Black or African American only",2019,14.0,"per 100,000",,,0.180,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","White only",2019,12.3,"per 100,000",,,0.074,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","2 or more races",2019,4.7,"per 100,000",,,0.264,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Hispanic or Latino",2019,6.3,"per 100,000",,,0.103,"United States",3,5.946,1,6.67, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino",2019,12.6,"per 100,000",,,0.072,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: American Indian or Alaska Native only",2019,10.8,"per 100,000",,,0.687,"United States",4,10.131,1,11.811, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Asian only",2019,1.1,"per 100,000",,,0.072,"United States",1,1,1,1.171, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Native Hawaiian or Other Pacific Islander only",2019,DSU,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Black or African American only",2019,14.4,"per 100,000",,,0.188,"United States",6,13.551,1,15.185,0.078 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: White only",2019,14.0,"per 100,000",,,0.090,"United States",5,13.174,1,14.74, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: 2 or more races",2019,5.1,"per 100,000",,,0.310,"United States",2,4.8,1,5.577, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","less than 18 years",2019,0.2,"per 100,000",,,0.018,"United States",1,1,1,1.195, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 0-4 years",2019,0.2,"per 100,000",,,0.032,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 5-11 years",2019,DSU,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 12-17 years",2019,0.5,"per 100,000",,,0.045,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years",2019,19.4,"per 100,000",,,0.128,"United States",4,82.951,1,94.113,0.077 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years: 18-24 years",2019,9.7,"per 100,000",,,0.179,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years: 25-44 years",2019,22.8,"per 100,000",,,0.161,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years",2019,14.6,"per 100,000",,,0.132,"United States",3,62.401,1,70.827, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years: 45-54 years",2019,17.3,"per 100,000",,,0.206,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years: 55-64 years",2019,12.0,"per 100,000",,,0.168,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over",2019,2.1,"per 100,000",,,0.062,"United States",2,8.921,1,10.21, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 65-74 years",2019,3.3,"per 100,000",,,0.103,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 75-84 years",2019,0.5,"per 100,000",,,0.054,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 85 years and over",2019,DSU,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","Less than High school",2019,36.1,"per 100,000",,,0.473,"United States",2,4.323,1,4.445, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","High school (including GED or equivalent)",2019,40.4,"per 100,000",,,0.324,"United States",3,4.84,1,4.948,0.018 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","Some college or more",2019,8.3,"per 100,000",,,0.090,"United States",1,1,1,1.025, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Family income *","Family income",2019,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Health insurance status *","Health insurance status",2019,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Geographic location *",Metropolitan,2019,11.9,"per 100,000",,,0.067,"United States",2,1.438,1,1.482,0.019 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Geographic location *",Non-metropolitan,2019,8.3,"per 100,000",,,0.147,"United States",1,1,1,1.042,0.025 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *",Married,2019,4.8,"per 100,000",,,0.066,"United States",1,1,1,1.032, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *","Divorced, separated, widowed",2019,28.2,"per 100,000",,,0.394,"United States",2,5.822,1,6.012, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *","Never married",2019,35.5,"per 100,000",,,0.294,"United States",3,7.338,1,7.533,0.021 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Country of birth *",US,2019,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Country of birth *","Outside US",2019,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Veteran status *","Veteran status",2019,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Disability status *","Disability status",2019,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sexual orientation *","Sexual orientation",2019,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Gender identity *","Gender identity",2019,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Total *",Total,2020,17.8,"per 100,000",,,0.076,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sex *",Male,2020,25.9,"per 100,000",,,0.130,"United States",2,2.702,1,2.745,0.01 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sex *",Female,2020,9.6,"per 100,000",,,0.079,"United States",1,1,1,1.019,0.012 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","American Indian or Alaska Native only",2020,13.4,"per 100,000",,,0.570,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Asian only",2020,2.3,"per 100,000",,,0.105,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Native Hawaiian or Other Pacific Islander only",2020,4.1,"per 100,000",,,0.697,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Black or African American only",2020,23.2,"per 100,000",,,0.230,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","White only",2020,18.7,"per 100,000",,,0.091,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","2 or more races",2020,9.2,"per 100,000",,,0.361,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Hispanic or Latino",2020,10.7,"per 100,000",,,0.133,"United States",4,4.847,1,5.259, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino",2020,19.4,"per 100,000",,,0.089,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: American Indian or Alaska Native only",2020,21.6,"per 100,000",,,0.971,"United States",6,9.787,1,10.906, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Asian only",2020,2.2,"per 100,000",,,0.106,"United States",1,1,1,1.118, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Native Hawaiian or Other Pacific Islander only",2020,4.5,"per 100,000",,,0.845,"United States",2,2.045,1,2.812, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Black or African American only",2020,24.1,"per 100,000",,,0.243,"United States",7,10.929,1,11.847,0.063 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: White only",2020,20.9,"per 100,000",,,0.110,"United States",5,9.479,1,10.263, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: 2 or more races",2020,9.8,"per 100,000",,,0.424,"United States",3,4.439,1,4.938, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","less than 18 years",2020,0.6,"per 100,000",,,0.028,"United States",1,1,1,1.12, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 0-4 years",2020,0.3,"per 100,000",,,0.040,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 5-11 years",2020,DSU,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 12-17 years",2020,1.4,"per 100,000",,,0.075,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years",2020,30.3,"per 100,000",,,0.160,"United States",4,52.301,1,56.687,0.05 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years: 18-24 years",2020,16.9,"per 100,000",,,0.237,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years: 25-44 years",2020,34.9,"per 100,000",,,0.199,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years",2020,22.4,"per 100,000",,,0.164,"United States",3,38.593,1,41.848, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years: 45-54 years",2020,26.6,"per 100,000",,,0.257,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years: 55-64 years",2020,18.3,"per 100,000",,,0.208,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over",2020,3.1,"per 100,000",,,0.075,"United States",2,5.401,1,5.905, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 65-74 years",2020,5.0,"per 100,000",,,0.124,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 75-84 years",2020,0.6,"per 100,000",,,0.062,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 85 years and over",2020,DSU,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","Less than High school",2020,58.8,"per 100,000",,,0.627,"United States",2,4.843,1,4.954, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","High school (including GED or equivalent)",2020,65.8,"per 100,000",,,0.424,"United States",3,5.414,1,5.512,0.015 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","Some college or more",2020,12.2,"per 100,000",,,0.107,"United States",1,1,1,1.021, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Family income *","Family income",2020,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Health insurance status *","Health insurance status",2020,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Geographic location *",Metropolitan,2020,18.3,"per 100,000",,,0.083,"United States",2,1.276,1,1.306,0.014 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Geographic location *",Non-metropolitan,2020,14.3,"per 100,000",,,0.193,"United States",1,1,1,1.032,0.019 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *",Married,2020,7.2,"per 100,000",,,0.080,"United States",1,1,1,1.026, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *","Divorced, separated, widowed",2020,45.8,"per 100,000",,,0.520,"United States",2,6.392,1,6.561, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *","Never married",2020,54.4,"per 100,000",,,0.363,"United States",3,7.583,1,7.746,0.017 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Country of birth *",US,2020,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Country of birth *","Outside US",2020,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Veteran status *","Veteran status",2020,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Disability status *","Disability status",2020,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sexual orientation *","Sexual orientation",2020,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Gender identity *","Gender identity",2020,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Total *",Total,2021,21.8,"per 100,000",,,0.084,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sex *",Male,2021,31.4,"per 100,000",,,0.141,"United States",2,2.583,1,2.62,0.009 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sex *",Female,2021,12.2,"per 100,000",,,0.089,"United States",1,1,1,1.017,0.01 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","American Indian or Alaska Native only",2021,20.9,"per 100,000",,,0.706,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Asian only",2021,2.4,"per 100,000",,,0.106,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Native Hawaiian or Other Pacific Islander only",2021,8.9,"per 100,000",,,1.021,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Black or African American only",2021,30.3,"per 100,000",,,0.261,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","White only",2021,22.6,"per 100,000",,,0.099,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","2 or more races",2021,12.0,"per 100,000",,,0.411,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Hispanic or Latino",2021,14.2,"per 100,000",,,0.152,"United States",4,6.332,1,6.853, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino",2021,23.5,"per 100,000",,,0.097,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: American Indian or Alaska Native only",2021,33.6,"per 100,000",,,1.205,"United States",7,15,1,16.529,0.06 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Asian only",2021,2.2,"per 100,000",,,0.105,"United States",1,1,1,1.115, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Native Hawaiian or Other Pacific Islander only",2021,8.9,"per 100,000",,,1.190,"United States",2,3.99,1,5.034, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: Black or African American only",2021,31.4,"per 100,000",,,0.274,"United States",6,14.02,1,15.163, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: White only",2021,24.8,"per 100,000",,,0.119,"United States",5,11.098,1,11.991, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Race/Ethnicity *","Not Hispanic or Latino: 2 or more races",2021,13.1,"per 100,000",,,0.490,"United States",3,5.861,1,6.468, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","less than 18 years",2021,0.8,"per 100,000",,,0.034,"United States",1,1,1,1.098, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 0-4 years",2021,0.7,"per 100,000",,,0.061,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 5-11 years",2021,DSU,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","<18 years: 12-17 years",2021,1.8,"per 100,000",,,0.084,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years",2021,36.2,"per 100,000",,,0.174,"United States",4,42.764,1,45.698,0.041 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years: 18-24 years",2021,18.3,"per 100,000",,,0.247,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","18-44 years: 25-44 years",2021,42.3,"per 100,000",,,0.218,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years",2021,29.1,"per 100,000",,,0.187,"United States",3,34.31,1,36.678, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years: 45-54 years",2021,33.1,"per 100,000",,,0.285,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","45-64 years: 55-64 years",2021,25.2,"per 100,000",,,0.243,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over",2021,4.7,"per 100,000",,,0.092,"United States",2,5.54,1,5.961, "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 65-74 years",2021,7.3,"per 100,000",,,0.147,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 75-84 years",2021,0.9,"per 100,000",,,0.075,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Age group","65 years and over: 85 years and over",2021,0.4,"per 100,000",,,0.078,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","Less than High school",2021,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","High school (including GED or equivalent)",2021,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Educational attainment (25-64 years) *","Some college or more",2021,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Family income *","Family income",2021,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Health insurance status *","Health insurance status",2021,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Geographic location *",Metropolitan,2021,22.2,"per 100,000",,,0.090,"United States",2,1.144,1,1.167,0.012 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Geographic location *",Non-metropolitan,2021,19.4,"per 100,000",,,0.224,"United States",1,1,1,1.027,0.016 "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *",Married,2021,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *","Divorced, separated, widowed",2021,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Marital status (25 years and over) *","Never married",2021,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Country of birth *",US,2021,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Country of birth *","Outside US",2021,DNA,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Veteran status *","Veteran status",2021,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Disability status *","Disability status",2021,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Sexual orientation *","Sexual orientation",2021,DNC,"per 100,000",,,,"United States" "Reduce overdose deaths involving synthetic opioids other than methadone - IVP-22",IVP-22,"Gender identity *","Gender identity",2021,DNC,"per 100,000",,,,"United States" Footnotes "*: Age adjusted to the year 2000 standard population." "DSU: Data do not meet the criteria for statistical reliability, data quality, or confidentiality." "DNA: Data have not been analyzed." "DNC: Data for specific population not collected." "--- : Data are not available." "Data Sources" "National Vital Statistics System - Mortality (NVSS-M)" "Population Estimates"